You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Med., 10 July 2023

Sec. Gene and Cell Therapy

Volume 10 - 2023 | https://doi.org/10.3389/fmed.2023.1244638

Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma

  • 1. Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

  • 2. Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, China

  • 3. Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

Article metrics

View details

2

Citations

1,6k

Views

840

Downloads

In the published article, there was an error in affiliation 1. Instead of “Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Xiamen, China”, it should be “Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China”.

In the published article, there was an error in affiliation 2. Instead of “Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, China”, it should be “Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, China”.

In the published article, there was an error in affiliation 3. Instead of “Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, Xiamen, China”, it should be “Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China”.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

Cuproptosis, glioma, prognostic biomarker, immune infiltration, lipoylation

Citation

Lu H, Zhou L, Zhang B, Xie Y, Yang H and Wang Z (2023) Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma. Front. Med. 10:1244638. doi: 10.3389/fmed.2023.1244638

Received

22 June 2023

Accepted

23 June 2023

Published

10 July 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

10 - 2023

Updates

Copyright

*Correspondence: Zhanxiang Wang

†These authors share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics